Jakob Dupont
Direttore/Membro del Consiglio presso IMUGENE LIMITED
Patrimonio netto: 167 114 $ in data 31/05/2024
Profilo
Jakob Dupont is currently a Non-Executive Director at Imugene Ltd., a Director at Apexigen America, Inc., an Independent Director at Pyxis Oncology, Inc., an Executive Partner at Sofinnova Investments, Inc., and an Advisor at Ambrx, Inc. Previously, he worked as a Global Director-Medical at Genentech, Inc. from 2006 to 2011, an Independent Director at Apexigen, Inc. from 2020 to 2023, the VP & Global Head-Gynecologic Cancer Development at Genentech, Inc. from 2017 to 2018, the Chief Medical Officer & Senior Vice President at Mereo BioPharma 5, Inc. from 2011 to 2017, and the Chief Medical Officer at Gossamer Bio, Inc. from 2018 to 2020.
Dr. Dupont's education includes a graduate degree from New York University in 1991, an undergraduate degree from Vassar College in 1987, and a doctorate degree from Weill Cornell Medical College in 1996.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/03/2023 | 290 794 ( 0.24% ) | 163 135 $ | 31/05/2024 | |
IMUGENE LTD
0.00% | 12/01/2024 | 89 286 ( 0.00% ) | 3 979 $ | 31/05/2024 |
PYXIS ONCOLOGY, INC.
-.--% | 18/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Jakob Dupont
| Società | Posizione | Inizio |
|---|---|---|
| IMUGENE LIMITED | Direttore/Membro del Consiglio | 07/09/2022 |
| AMBRX INC | Consulente / Consigliere | 01/03/2021 |
| PYXIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 23/08/2023 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Direttore/Membro del Consiglio | 19/08/2020 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investitore di Private Equity | 01/05/2023 |
Precedenti posizioni note di Jakob Dupont
| Società | Posizione | Fine |
|---|---|---|
| APEXIGEN, INC. | Direttore/Membro del Consiglio | 23/08/2023 |
| ATARA BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 12/05/2023 |
| GOSSAMER BIO, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/12/2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jakob Dupont
| New York University | Graduate Degree |
| Vassar College | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
- Borsa valori
- Insiders
- Jakob Dupont
